Enzymogen

Enzymogen Enzymogen utilizes biosynthetic and biocatalytic techniques to produce large quantities of a variety of cannabinoids.

Cannabinoids are proving to be valuable drug targets, and have generated much interest among pharma companies.​

Current production methods involve plant extraction which does not produce sufficient yield for manufacturing. Enzymogen develops new drugs for unmet needs based on cannabinoid data, by using its proprietary technology for production of active pharmaceutical ingredients.

Address

19 Hidekel
Yavne

Alerts

Be the first to know and let us send you an email when Enzymogen posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share